Growth-hormone research
Tesamorelin
TH9507
Stabilized GHRH analog · Visceral adipose research
A synthetic analog of human GHRH(1-44) stabilized by N-terminal trans-3-hexenoic acid. A GHRH analog studied in GH/IGF-1 axis and adipose-tissue pathway literature.
For laboratory research use only. Not for human or animal consumption, not a drug, food, cosmetic, or supplement. By adding to cart, the researcher affirms compliance with all applicable regulations.
Selected research material
Tesamorelin
5mg vial · SKU VRL-TES-5
Choose vial size
COA record
VRL-TES-2601
Secure checkout
Waave
Fulfillment
Cold-chain
Research price
$79
RUO only · Lot-matched documentation · Cold-chain handling
Specifications
Tesamorelin is a stabilized 44-amino-acid analog of human growth hormone releasing hormone. A trans-3-hexenoic acid modification at the N-terminus confers resistance to enzymatic degradation and extends circulating half-life in published pharmacokinetic studies.
Tesamorelin is described in published GHRH analog literature, where clinical literature has documented reductions in visceral adipose tissue. In broader research contexts, the peptide is studied as a tool for examining GH/IGF-1 axis modulation and ectopic fat deposition.
Provided only as a research reagent; not for therapeutic, diagnostic, cosmetic, or human/veterinary use.
Related research tools
